James

WHO Expert Committee on Drug Dependence (ECDD) Information Repository

Shared by James - 5 June 2023
WHO Expert Committee on Drug Dependence (ECDD) Information Repository
Format
Websites
On Thursday, June 1st, the WHO launched the Expert Committee on Drug Dependence (ECDD) Information Repository, which provides health professionals and drug policy experts with a single searchable database to freely access all technical reports on over 450 substances reviewed by the ECDD.
Jose Luis Vazquez Martinez

Webinar “Fentanilo: Un Problema Actual”

Jose Luis Vazquez Martinez - 31 May 2023
Date:
21 Jun 2023
Country
United States
Registro: https://us06web.zoom.us/webinar/register/7616826968373/WN_tkHV_zYrQZON3GVPSFXT4Q#/registration El miércoles 21 de junio del 2023, de 10:00 a 14:00 ET (hora de Washingotn, DC), la Secretaria Ejecutiva de la Comisión Interamericana para el Control del Abuso de Drogas (SE-CICAD), la Organización Panamericana de la Salud (OPS) y el Ayuntamiento de Valencia, España, invitan al webinar "Fentanilo: Un Problema Actual". Ponentes Marya Hynes - Jefa, Observatorio Interamericano sobre Drogas, CICAD. Lucía Teresa Hipólito Cubedo - Twitter: https://twitter.com/Luciahipolito2 Profesora Titular...
Bartolome Perez-Galvez

Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis.

Bartolome Perez-Galvez - 27 May 2023
Source: Snowdon, J., & Choi, N. (2022). Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis. International journal of mental health and addiction, 1–19. Advance online publication. https://doi.org/10.1007/s11469-022-00932-9
Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis_0.pdf
Bartolome Perez-Galvez

Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).

Bartolome Perez-Galvez - 27 May 2023
Source: Marel, C., Wilson, J., Darke, S., Ross, J., Slade, T., Haber, P. S., Haasnoot, K., Visontay, R., Keaveny, M., Tremonti, C., Mills, K. L., & Teesson, M. (2023). Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the...
Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence - Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS)_1.pdf
Jose Luis Vazquez Martinez

La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides

Jose Luis Vazquez Martinez - 24 May 2023

Fuente: https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-una-nueva-opcion-de-tratamiento-con-buprenorfina-para-el-trastorno-por-consumo-de

 

Para publicación inmediata: 24 de mayo del 2023

Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi (buprenorfina) de liberación prolongada para tratar el trastorno por consumo de opioides (OUD, por sus siglas en inglés) de moderado a grave. Brixadi está disponible en dos formulaciones, una inyección...

Jose Luis Vazquez Martinez

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

Jose Luis Vazquez Martinez - 24 May 2023

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder

 

For Immediate Release: May 23, 2023

Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two formulations, a weekly injection that can be used in patients who have started treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine...

Jose Luis Vazquez Martinez

Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder

Jose Luis Vazquez Martinez - 23 May 2023
Source: https://store.samhsa.gov/sites/default/files/pep23-02-01-002.pdf This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of...
Advisory Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder_1.pdf
Jose Luis Vazquez Martinez

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes

Jose Luis Vazquez Martinez - 22 May 2023
Source: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Netw Open. 2023;6(5):e2314328. doi:10.1001/jamanetworkopen.2023.14328 Key Points Question Did rates of methadone dispensing for opioid use...
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes_0.pdf
Jose Luis Vazquez Martinez

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

Jose Luis Vazquez Martinez - 22 May 2023
Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder opportunities for training innovation_0.pdf
Edie

Buprenorphine versus methadone for the treatment of opioid dependence

Shared by Edie - 11 May 2023
Citation
Degenhardt, L., Clark, B., Macpherson, G., Leppan, O., Nielsen, S., Zahra, E., ... & Farrell, M. (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry.

Summary

Background

Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are common medications provided as OAT. We...

Jose Luis Vazquez Martinez

Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review

Jose Luis Vazquez Martinez - 9 May 2023
Source: Onuoha, E. N., Leff, J. A., Schackman, B. R., McCollister, K. E., Polsky, D., & Murphy, S. M. (2021). Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review. Value in Health, 24(7), 1068-1083. Highlights There is new evidence on buprenorphine...
Click here → to read the full text
Jose Luis Vazquez Martinez

Fentanilo, de lo Molecular a lo Social - Dr. Carlos Galicia Galicia

Jose Luis Vazquez Martinez - 27 February 2023
Ponente: Dr. Carlos Galicia Galicia Los objetivos del seminario son conocer el fentanilo de uso médico y diferenciarlo del producido clandestinamente. Además, presentar los fundamentos neurobiológicos del consumo compulsivo de fentanilo.
Jose Luis Vazquez Martinez

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

Jose Luis Vazquez Martinez - 14 February 2023
Source: Hooker, S. A., Crain, A. L., LaFrance, A. B., Kane, S., Fokuo, J. K., Bart, G., & Rossom, R. C. (2023). A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addiction Science & Clinical Practice, 18(1), 1-10...
A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians_0.pdf
Rasha Abi Hana

Prevention of Opioid Use Education Materials

Shared by Rasha Abi Hana - 7 November 2022
Format
Toolkits
Created by
Mid-America ATTC (MATTC)

Mid-America Addiction Technology Transfer Center (MATTC) partnered with the Ethnic Communities Opioid Response Network in Missouri, the Addiction Policy Forum, and the Opioid Response Network (ORN in IA, KS, MO, and NE) to translate 5 different evidence-based prevention products "Prevention of Opioid Use Education Materials"  into 12 different languages, and ensure they are culturally appropriate, including Arabic, Bosnian, Burmese, Dari, French, Mandarin Chinese, Pashto, Somali, Spanish, Swahili, Tagalog (Filipino) and Ukrainian.

 

Translations
Қазақ
Ελληνικά
Italian
Edie

Problematic opioid use in Ireland, 2015–2019

Shared by Edie - 15 October 2022
Published by
Health Research Board

In this report, the Health Research Board presents the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. 

Key Findings:

In total, there were an estimated 19,875 problematic opioid users...

Translations
پښتو‎
Česky
Urdu
Edie

Global trends in opioid medicine availability

Shared by Edie - 5 October 2022
Format
Webinars
Created by
NDARC

This webinar presented the latest global and regional trends in the use of opioid analgesics and explore issues related to availability.

Around the world the consumption of opioid analgesics has been increasing, yet millions of people still die in pain every year, including children, mostly in poor countries, but also in rural areas in developed countries.

Observing the trends in use of these medications is relevant to determine which medicines are being used and if the international market is distributing mostly newer and less affordable formulations, to determine any changes in the...

Jose Luis Vazquez Martinez

Cooperative Extension professionals' knowledge and attitudes toward the opioid epidemic: Implications for capacity development and outreach

Jose Luis Vazquez Martinez - 23 August 2022
Source: Washburn LT, Franck KL, Upendram S and Yenerall JN (2022) Cooperative Extension professionals’ knowledge and attitudes toward the opioid epidemic: Implications for capacity development and outreach. Front. Psychiatry 13:958335. doi: 10.3389/fpsyt.2022.958335 Introduction: Worsening of the...
Cooperative Extension professionals' knowledge and attitudes toward the opioid epidemic Implications for capacity development and outreach.pdf
Jose Luis Vazquez Martinez

Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial

Jose Luis Vazquez Martinez - 19 August 2022
Source: Dolan AR, Goldberg EB, Cannuscio CC, et al. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2227650. doi:10.1001/jamanetworkopen.2022.27650 Key Points Question What can be learned about patient experiences...
Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial.pdf
Jose Luis Vazquez Martinez

Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose A Randomized Clinical Trial

Jose Luis Vazquez Martinez - 11 August 2022
Source: Beaudoin FL, Jacka BP, Li Y, et al. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2225582. doi:10.1001/jamanetworkopen.2022.25582 Key Points Question Can peer-led...
Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose_0.pdf

Upcoming Events

Webinar “Fentanilo: Un Problema Actual”

21 Jun 2023
United States
Registro: https://us06web.zoom.us/webinar/register/7616826968373/WN_tkHV_zYrQZON3GVPSFXT4Q#/registration El miércoles 21 de junio del 2023, de 10:00 a 14:00 ET (hora de Washingotn, DC), la Secretaria Ejecutiva de la Comisión Interamericana...
Contact Us
Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy